Pharmacovigilance deep dive: risk minimisation measures
European Pharmaceutical Review
SEPTEMBER 2, 2022
This article explores just one aspect of the RMP, that of RMMs, and how their effectiveness is measured with Dr Sophie Jouaville, an associate principal at IQVIA working on the design and oversight of non-interventional real-world evidence (RWE) safety and health economics and outcomes research (HEOR) studies. Available from: [link].
Let's personalize your content